Wolfson Centre for Age-Related Diseases, Institute of Psychiatry, Psychology & Neuroscience, King's College London.
NIHR-Wellcome Trust King's Clinical Research Facility/SLaM Biomedical Research Centre, King's College Hospital, London, UK.
Curr Opin Neurol. 2022 Jun 1;35(3):336-342. doi: 10.1097/WCO.0000000000001055.
The pathophysiological understanding of cluster headache has evolved significantly over the past years. Although it is now well known that the trigeminovascular system, the parasympathetic system and the hypothalamus play important roles in its pathomechanism, we increasingly understand the functional role several neurotransmitters and hormones play in the communication between these structures.
This work will give an overview of the current understanding of the role of calcitonin gene-related peptide, vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, melatonin and orexins in cluster headache. On the basis of recent evidence, this study will also review the relevance of the monoclonal calcitonin gene-related peptide antibody galcanezumab as well as the sleep-regulating hormone melatonin in the treatment of cluster headache.
Herein, we aim to review the basic mechanisms implicated in the pathophysiology of cluster headache and how the increased mechanistic understanding may lead to the discovery of novel therapeutic targets.
近年来,对集群性头痛的病理生理学认识有了显著的发展。尽管现在众所周知,三叉神经血管系统、副交感神经系统和下丘脑在其发病机制中起着重要作用,但我们越来越了解几种神经递质和激素在这些结构之间的通讯中所起的功能作用。
这项工作将概述降钙素基因相关肽、血管活性肠肽、垂体腺苷酸环化酶激活肽、褪黑素和食欲素在集群性头痛中的作用。基于最近的证据,本研究还将回顾单克隆降钙素基因相关肽抗体加兰他敏以及调节睡眠的激素褪黑素在治疗集群性头痛中的相关性。
本文旨在综述集群性头痛发病机制中涉及的基本机制,以及对发病机制的深入理解如何可能导致新的治疗靶点的发现。